
Surmodics, Inc.
Surmodics, Inc. (SRDX) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
srdx · stock forecast · 7 analysts (3M) · FMP · updated Nov 26, 2025
Analyst Rating & Consensus
Based on 7 Wall Street analysts in the past 3 months
Buy
7 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$43.00
Consensus
$39.50
-8.1% upside
Low
$36.00
Median: $39.5 · Last Close: $42.98
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$39.50
-8.1% upside
High Target
$43
0.0%
Low Target
$36
-16.2%
Current Price
$42.98
as of today
Based on analyst price targets, the SRDX stock price prediction for the next 12 months ranges from $36 to $43. The consensus SRDX price forecast of $39.50 implies -8.1% upside from the current price of $42.98.
Short-Term Price Prediction
RangingAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $42.98 | ↑ 0.00% |
1-day model range: $42.92–$43.04. Peak: $43.04 (+0.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · SRDX · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-11-14 | Barrington Research | Downgrade ↓ | Market Perform→Underperform |
| 2025-08-11 | Barrington Research | Maintains | Market Perform→Market Perform |
| 2025-04-30 | Needham | Maintains | Hold→Hold |
| 2025-03-07 | Lake Street | Upgrade ↑ | Hold→Buy |
| 2025-01-30 | Needham | Maintains | Hold→Hold |
| 2024-05-30 | Barrington Research | Downgrade ↓ | Outperform→Market Perform |
| 2024-05-29 | Needham | Downgrade ↓ | Buy→Hold |
| 2024-05-29 | Sidoti & Co. | Downgrade ↓ | Buy→Neutral |
| 2024-05-29 | Lake Street | Downgrade ↓ | Buy→Hold |
| 2024-05-02 | Barrington Research | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Surmodics, Inc. (SRDX) stock. Of the recent 43 rating actions, 7 were upgrades and 10 were downgrades. 7 analysts currently cover SRDX.
Analyst Recommendation Trends
SRDX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$138M
↑ 17.3% YoY
Revenue Next Year
$123M
↓ 10.8% YoY
EPS This Year
$0.39
EPS Next Year
$-0.56
↓ 241.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast SRDX EPS of $0.39 for the current fiscal year, based on estimates from 1 analysts. The SRDX revenue forecast is $138M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The SRDX stock forecast is supported by two independent data sources: analyst consensus ratings from 7 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus SRDX price target is $39.50 (-8.1% upside), with an analyst consensus of Buy.
The SRDX short-term stock prediction for tomorrow is $42.98 (+0.00%).
Surmodics, Inc. trades on NASDAQ under the ticker SRDX. The SRDX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 57% of covering analysts.
Frequently asked questions
SRDX forecast · 8 questionsAccording to 7 Wall Street analysts, the average 12-month SRDX price target is $39.50, with a high forecast of $43.00 and a low of $36.00. The median price target is shown in the chart above when available. This implies -8.1% potential upside from the current price of $42.98.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.